SPY423.11+2.25 0.53%
DIA339.45+0.67 0.20%
IXIC14,253.27+111.79 0.79%

--Oppenheimer Adjusts Bicycle Therapeutics PT to $44 From $38 Following Q1 Results, Maintains Outperform Rating

05/11/2021 07:09

10:53 AM EDT, 05/11/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)

Price: 30.99, Change: +0.14, Percent Change: +0.45